Suppr超能文献

局部复发性鼻咽癌的治疗管理。

Management of locally recurrent nasopharyngeal carcinoma.

机构信息

Department of Clinical Oncology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong; Clinical Oncology Center, The University of Hong Kong-Shenzhen Hospital, Shenzhen, People's Republic of China.

Department of Clinical Oncology, Pamela Youde Nethersole Eastern Hospital, Hong Kong.

出版信息

Cancer Treat Rev. 2019 Sep;79:101890. doi: 10.1016/j.ctrv.2019.101890. Epub 2019 Aug 21.

Abstract

As a consequence of the current excellent loco-regional control rates attained using the generally accepted treatment paradigms involving intensity-modulated radiotherapy for nasopharyngeal carcinoma (NPC), only 10-20% of patients will suffer from local and/or nodal recurrence after primary treatment. Early detection of recurrence is important as localized recurrent disease is still potentially salvageable, but this treatment often incurs a high risk of major toxicities. Due to the possibility of radio-resistance of tumors which persist or recur despite adequate prior irradiation and the limited tolerance of adjacent normal tissues to sustain further additional treatment, the management of local failures remains one of the greatest challenges in this disease. Both surgical approaches for radical resection and specialized re-irradiation modalities have been explored. Unfortunately, available data are based on retrospective studies, and the majority of them are based on a small number of patients or relatively short follow-up. In this article, we will review the different salvage treatment options and associated prognostic factors for each of them. We will also propose a treatment algorithm based on the latest available evidence and discuss the future directions of treatment for locally recurrent NPC.

摘要

由于目前采用调强放疗等被广泛认可的治疗模式,鼻咽癌(NPC)的局部区域控制率非常出色,只有 10-20%的患者在初次治疗后会出现局部和/或淋巴结复发。早期发现复发非常重要,因为局部复发性疾病仍然有潜在的可治愈性,但这种治疗往往存在发生重大毒性的高风险。由于肿瘤在充分的前期照射后仍持续存在或复发的可能性,以及相邻正常组织对进一步额外治疗的耐受有限,局部失败的管理仍然是该疾病最大的挑战之一。根治性手术和专门的再放疗方式都已经被探索过了。不幸的是,现有数据基于回顾性研究,且大多数研究基于少数患者或相对较短的随访时间。在本文中,我们将回顾每种治疗方式的不同挽救性治疗选择及其相关的预后因素。我们还将根据最新的可用证据提出一种治疗算法,并讨论局部复发性 NPC 的未来治疗方向。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验